Giancarlo R. Guido

Pediatrics
2386 Jerome Ave
Bronx, NY 10468

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.

Journal: The Journal of investigative dermatology
Published: May 09, 2019
Showing 1-1 of 1

Last Updated: 09/26/2026